SLPI and lip and oral cavity carcinoma: Collectively, our results show for the first time a progressive loss of SLPI abundance in the transition from OPML to OSCC, and suggest a novel role for SLPI as a mechanism-linked, non-invasive biomarker of oral cancer, with potential as an OPML treatment agent.